StockData
MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF

MESOBLAST LTD

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 27, 2026
$11.95−1.33 (-10.02%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

MESOBLAST LTD revenue by segment

No segment breakdown reported

Mesoblast does not break out revenue by segment, region or product in the tagged data of its filings for this period type.